{"ok":true,"trend":{"id":754349,"platform":"news","region":"global","key":"biomarin announces five-year phase 3 data for pombiliti® (cipaglucosidase alfa-atga) + opfolda® (miglustat) at world muscle society annual congress","title":"BioMarin Announces Five-Year Phase 3 Data for POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at World Muscle Society Annual Congress","url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxQNHRzRk0yN0RFXzB2TlktblRwT0k5dXd5YVV2bzM3S0RJeENOTjlfODY4QVZHTW03ck9sWEx6ZC10c3Bqd3FDVHV0Q2dSNW5oenlYX0R3RS1wMDNrMi1LYWdLV0ZQT25vd2lrNU1Ta1ViMERBdk1ydno5MjNNMUV6ZC1hRnpNZy1pcEVJNmVjN09EVHBtbTJ0dWlBaVhxMC1OclRjUFZGdWJObzliRlBOYldLbDB1VTl5aDRwa0xGMUV5TWphN3pWYk9LRUtpb1FIOUxiN0J6ck5pV0VvdmRkUjZoQXV2QkR2b1JJQWdRRGtSa0szTDJ6QVNWREVKMTFGU01MUENucWhBSjFLSDNUS3FJdnVlaFhXRXU5d21MVldUQQ?oc=5","first_seen":"2026-10-02T16:29:33.971863Z","last_seen":"2026-10-02T19:14:16.125639Z","last_rank":29,"peak_rank":20,"last_volume":null,"peak_volume":0,"seen_count":3,"score":25.99,"category_hint":"us_politics","section":"world","category":"us_politics","summary":"BioMarin announced five-year Phase 3 data for Pombiliti (cipaglucosidase alfa-atga) combined with Opfolda (miglustat), presented at the World Muscle Society Annual Congress. The long-term results concern the company's enzyme replacement therapy for late-onset Pompe disease, and the announcement was issued via press release. The new data points were shared with clinicians and researchers attending the congress.","why":"New long-term clinical data on a rare disease therapy was just presented at a major neuromuscular congress, drawing attention from the medical and patient communities.","tone":"neutral","entities":["BioMarin","Pombiliti","Opfolda","World Muscle Society"],"summarized_at":"2026-10-02T16:30:15.405564Z","meta":{"via":"scan","lang":"en","term":"congress","source":"PR Newswire","published":"Fri, 02 Oct 2026 15:00:00 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"BioMarin Presents Five-Year Phase 3 Data for Pombiliti Therapy","section_name":"World","category_name":"US Politics","timeline":[{"captured_at":"2026-10-02T16:29:33.971863Z","rank":20,"volume":null},{"captured_at":"2026-10-02T17:52:12.984339Z","rank":20,"volume":null},{"captured_at":"2026-10-02T19:14:16.125639Z","rank":29,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxQNHRzRk0yN0RFXzB2TlktblRwT0k5dXd5YVV2bzM3S0RJeENOTjlfODY4QVZHTW03ck9sWEx6ZC10c3Bqd3FDVHV0Q2dSNW5oenlYX0R3RS1wMDNrMi1LYWdLV0ZQT25vd2lrNU1Ta1ViMERBdk1ydno5MjNNMUV6ZC1hRnpNZy1pcEVJNmVjN09EVHBtbTJ0dWlBaVhxMC1OclRjUFZGdWJObzliRlBOYldLbDB1VTl5aDRwa0xGMUV5TWphN3pWYk9LRUtpb1FIOUxiN0J6ck5pV0VvdmRkUjZoQXV2QkR2b1JJQWdRRGtSa0szTDJ6QVNWREVKMTFGU01MUENucWhBSjFLSDNUS3FJdnVlaFhXRXU5d21MVldUQQ?oc=5","author":"PR Newswire","title":"BioMarin Announces Five-Year Phase 3 Data for POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at World Muscle Society Annual Congress","snippet":null,"posted_at":"2026-10-02T15:00:00Z","likes":null}],"elsewhere":[],"window":"7d"}}